Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы

Shakhnoza Niyozova

Работ: 7

Tashkent Medical Academy, Tashkent, Uzbekistan

  1. P15.06 * QUALITY OF PATIENTS LIFE WITH METASTATIC TUMORS OF THE SPINE AND SPINAL CORD

    S. G. Gazieva, N. Tolibova, Shakhnoza Niyozova +1

    СтатьяManagement of metastatic bone diseaseNeuro-Oncology2014Цитирований: 0
    ABI

  2. STUDY OF THE POSSIBILITIES OF PREOPERATIVE CHEMOTHERAPY IN MULTIPLE METASTASIS OF COLORECTAL CANCER IN THE LIVER

    Kh.D. Islamov, Shakhnoza Niyozova

    СтатьяHepatocellular Carcinoma Treatment and PrognosisEurasianUnionofScientists2020Цитирований: 0
    ABI

  3. Study of the effectiveness of chemotherapy in patients with colorectal cancer depending on the location of the metastatic lesion.

    Sergey Viktorovich Kamishov, Shakhnoza Niyozova

    СтатьяColorectal Cancer Treatments and StudiesJournal of Clinical Oncology2022Цитирований: 0
    ABI

  4. Effectiveness and safety of combined therapy with pemetrexed and bevacizumab in recurrent and metastatic cervical cancer.

    Shakhnoza Niyozova, Kamila Izrailbekova, Sergey Kamishov +3

    СтатьяEndometrial and Cervical Cancer TreatmentsJournal of Clinical Oncology2025Цитирований: 0
    ABI

  5. Results of combined therapy with pemetrexed and carboplatin in progressive ovarian cancer.

    Kamila Izrailbekova, Shakhnoza Niyozova, Sergey Kamishov +3

    СтатьяOvarian cancer diagnosis and treatmentJournal of Clinical Oncology2025Цитирований: 0
    ABI

  6. EFFICACY OF EVEROLIMUS IN COMBINATION WITH LETROZOLE, MEGESTROL ACETATE, AND PACLITAXEL FOR RECURRENT ENDOMETRIAL CANCER

    Kamishov Sergey Viktorovich, Shakhnoza Niyozova, Kamila Izrailbekova +2

    СтатьяEndometrial and Cervical Cancer TreatmentsMedical science of Uzbekistan2025Цитирований: 0
    ABI

  7. Immunotherapy for advanced gastric cancer: Experience from Uzbekistan.

    Kamila Izrailbekova, Sergey Kamishov, Askar Adilkhodjaev +3

    СтатьяGastric Cancer Management and OutcomesJournal of Clinical Oncology2026Цитирований: 0
    ABI